In the ever-expanding world of biotechnology, cells taken from aborted fetuses are considered as an up-and-coming resource while creating a huge controversy. On one hand, fetal tissue is said to have several properties that make it superior to the use of mature tissue. It is proving promising and receiving acclaim for treating disorders such as Parkinson's disease as well as spinal cord injuries. Conversely, arguments over the sanctity of life hold sway. This program traces the use of fetal cells in Japan, the U.S. and China, presenting a cause for hope and an ethical dilemma.